View Future GrowthThis company is no longer activeThe company may no longer be operating, as it may be out of business. Find out why through their latest events.See Latest EventsMurphy Canyon Acquisition 과거 순이익 실적과거 기준 점검 2/6Murphy Canyon Acquisition의 연간 평균 수익은 196.2%였으며, Capital Markets 산업의 수익은 연간 6.1% 증가했습니다.핵심 정보196.19%순이익 성장률n/a주당순이익(EPS) 성장률Capital Markets 산업 성장률10.26%매출 성장률n/a자기자본이익률n/a순이익률n/a최근 순이익 업데이트30 Jun 2023최근 과거 실적 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Sep 22Murphy Canyon Acquisition Corp., Conduit Merger Sub, Inc and Conduit Pharmaceuticals Limited Approve Board ElectionsMurphy Canyon Acquisition Corp. announced that at its EGM held on September 20, 2023, the shareholders approved election of Freda Lewis-Hall, David Tapolczay, James Bligh, Faith L. Charles, Chele Chiavacci Farley, Jennifer I. McNealey, and Andrew Regan as directors of New Conduit. The business combination (the Business Combination), as amended and supplemented, including the Agreement and Plan of Merger, dated as of November 8, 2022 and as amended on January 27, 2023 and May 11, 2023 (the Merger Agreement), by and among the company, Conduit Pharmaceuticals Limited (Conduit) and Conduit Merger Sub Inc. (Merger Sub), which, among other things, provides for the merger of Merger Sub with and into Conduit, with Conduit surviving the merger as a wholly-owned subsidiary of the company.공시 • Nov 10Conduit Pharmaceuticals Limited entered into a definitive Business Combination Agreement to acquire Murphy Canyon Acquisition Corp. (NasdaqGM:MURF) for $650 million in a reverse merger agreement.Conduit Pharmaceuticals Limited entered into a definitive Business Combination Agreement to acquire Murphy Canyon Acquisition Corp. (NasdaqGM:MURF) for $650 million in a reverse merger agreement on November 8, 2022. Murphy Canyon shall issue and deliver to the shareholders of Conduit an aggregate number of shares of Murphy Canyon’s common stock with an aggregate value equal to $650 million, with each share valued at $10.00 per share. The combined company is anticipated to have an estimated pro forma enterprise valuation of approximately $700.49 million. A private placement transaction shall be conducted by Murphy Canyon contemporaneously with the Business Combination (the “PIPE Financing”), pursuant to which Murphy Canyon has entered into subscription agreements providing for aggregate investments in Murphy Canyon’s securities of $27 million. The PIPE Investment is expected to close in connection with the business combination and is subject to the satisfaction of other customary closing conditions and a NASDAQ listing. After the closing of the Transactions and assuming no redemptions by Murphy’s public stockholders, existing Conduit shareholders will retain 100% of their equity ownership and will own approximately 76.48% of the pro forma combined company. The Company is expected to be renamed Conduit Pharmaceuticals Inc. at the closing of the Business Combination and is anticipated to be listed on NASDAQ under ticker symbol “CDT”. The combined company will continue to operate under the Conduit management team, led by David Tapolczay, Chief Executive Officer, and Freda Lewis-Hall, Chair of the Board of Directors. The Transactions, which have been unanimously approved by the boards of directors of both Conduit and Murphy, are subject to, among other customary closing conditions, approval by the stockholders of Murphy, and the shareholders of Conduit. The transaction is expected to close in the first quarter of 2023. Cash proceeds from the transaction are expected to consist of up to approximately $136.04 million of cash held in Murphy’s trust account and approximately $27 million attributable to a private investment anchored by new and existing investors of Conduit. A.G.P./Alliance Global Partners is serving as exclusive financial advisor to Conduit and Murphy. Thompson Hine LLP is serving as legal advisor to Conduit and Sichenzia Ross Ference LLP is serving as legal advisor to Murphy.공시 • Nov 09Murphy Canyon Acquisition Corp. announced that it expects to receive $27 million in fundingMurphy Canyon Acquisition Corp. announced that it has entered into subscription agreement for a private placement of $27,000,000 on November 8, 2022.공시 • May 17Murphy Canyon Acquisition Corp. announced delayed 10-Q filingOn 05/16/2022, Murphy Canyon Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.Seeking Alpha • Apr 04Murphy Canyon Acquisition Seeks Deal With Real Estate Proptech CompanyMurphy Canyon Acquisition Corp. went public recently, raising $132 million in an IPO. The SPAC seeks to merge with a company in the real estate Proptech industry. While MURF management has extensive industry experience, they don't have a previous SPAC track record, so I'm on Hold for the SPAC.매출 및 비용 세부 내역Murphy Canyon Acquisition가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이NasdaqGM:MURF 매출, 비용 및 순이익 (USD Millions)날짜매출순이익일반관리비연구개발비30 Jun 23012031 Mar 23011031 Dec 220010양질의 수익: MURF는 고품질 수익을 보유하고 있습니다.이익 마진 증가: 지난 1년 동안 MURF의 이익률이 개선되었는지 판단하기에 데이터가 부족합니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: MURF은 상장된 지 3년이 되지 않아 지난 5년간 전년 대비 수익 증가율이 긍정적인지 확인할 수 없습니다.성장 가속화: MURF은 상장된 지 3년이 되지 않아 지난 해 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: MURF의 지난 1년 수익 증가율(196.2%)은 Capital Markets 업계의 36.1%를 상회했습니다.자기자본이익률높은 ROE: MURF의 부채가 자산을 초과하여 자본 수익률을 계산하기 어렵습니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YDiversified-financials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2023/09/23 03:05종가2023/09/22 00:00수익2023/06/30연간 수익2022/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Murphy Canyon Acquisition Corp.는 0명의 분석가가 다루고 있습니다. 이 중 명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Sep 22Murphy Canyon Acquisition Corp., Conduit Merger Sub, Inc and Conduit Pharmaceuticals Limited Approve Board ElectionsMurphy Canyon Acquisition Corp. announced that at its EGM held on September 20, 2023, the shareholders approved election of Freda Lewis-Hall, David Tapolczay, James Bligh, Faith L. Charles, Chele Chiavacci Farley, Jennifer I. McNealey, and Andrew Regan as directors of New Conduit. The business combination (the Business Combination), as amended and supplemented, including the Agreement and Plan of Merger, dated as of November 8, 2022 and as amended on January 27, 2023 and May 11, 2023 (the Merger Agreement), by and among the company, Conduit Pharmaceuticals Limited (Conduit) and Conduit Merger Sub Inc. (Merger Sub), which, among other things, provides for the merger of Merger Sub with and into Conduit, with Conduit surviving the merger as a wholly-owned subsidiary of the company.
공시 • Nov 10Conduit Pharmaceuticals Limited entered into a definitive Business Combination Agreement to acquire Murphy Canyon Acquisition Corp. (NasdaqGM:MURF) for $650 million in a reverse merger agreement.Conduit Pharmaceuticals Limited entered into a definitive Business Combination Agreement to acquire Murphy Canyon Acquisition Corp. (NasdaqGM:MURF) for $650 million in a reverse merger agreement on November 8, 2022. Murphy Canyon shall issue and deliver to the shareholders of Conduit an aggregate number of shares of Murphy Canyon’s common stock with an aggregate value equal to $650 million, with each share valued at $10.00 per share. The combined company is anticipated to have an estimated pro forma enterprise valuation of approximately $700.49 million. A private placement transaction shall be conducted by Murphy Canyon contemporaneously with the Business Combination (the “PIPE Financing”), pursuant to which Murphy Canyon has entered into subscription agreements providing for aggregate investments in Murphy Canyon’s securities of $27 million. The PIPE Investment is expected to close in connection with the business combination and is subject to the satisfaction of other customary closing conditions and a NASDAQ listing. After the closing of the Transactions and assuming no redemptions by Murphy’s public stockholders, existing Conduit shareholders will retain 100% of their equity ownership and will own approximately 76.48% of the pro forma combined company. The Company is expected to be renamed Conduit Pharmaceuticals Inc. at the closing of the Business Combination and is anticipated to be listed on NASDAQ under ticker symbol “CDT”. The combined company will continue to operate under the Conduit management team, led by David Tapolczay, Chief Executive Officer, and Freda Lewis-Hall, Chair of the Board of Directors. The Transactions, which have been unanimously approved by the boards of directors of both Conduit and Murphy, are subject to, among other customary closing conditions, approval by the stockholders of Murphy, and the shareholders of Conduit. The transaction is expected to close in the first quarter of 2023. Cash proceeds from the transaction are expected to consist of up to approximately $136.04 million of cash held in Murphy’s trust account and approximately $27 million attributable to a private investment anchored by new and existing investors of Conduit. A.G.P./Alliance Global Partners is serving as exclusive financial advisor to Conduit and Murphy. Thompson Hine LLP is serving as legal advisor to Conduit and Sichenzia Ross Ference LLP is serving as legal advisor to Murphy.
공시 • Nov 09Murphy Canyon Acquisition Corp. announced that it expects to receive $27 million in fundingMurphy Canyon Acquisition Corp. announced that it has entered into subscription agreement for a private placement of $27,000,000 on November 8, 2022.
공시 • May 17Murphy Canyon Acquisition Corp. announced delayed 10-Q filingOn 05/16/2022, Murphy Canyon Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Seeking Alpha • Apr 04Murphy Canyon Acquisition Seeks Deal With Real Estate Proptech CompanyMurphy Canyon Acquisition Corp. went public recently, raising $132 million in an IPO. The SPAC seeks to merge with a company in the real estate Proptech industry. While MURF management has extensive industry experience, they don't have a previous SPAC track record, so I'm on Hold for the SPAC.